Nepal's first case of COVID-19 and public health response
R Shrestha, S Shrestha, P Khanal… - Journal of travel …, 2020 - academic.oup.com
As of 20 February 2020, there have been 75748 confirmed cases of the coronavirus disease
2019 (COVID-19) caused by the novel coronavirus (2019-nCov) with 2129 deaths. 1 On 30 …
2019 (COVID-19) caused by the novel coronavirus (2019-nCov) with 2129 deaths. 1 On 30 …
[HTML][HTML] Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - Springer
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-…
β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-…
Polypharmacy in elderly cancer patients: Challenges and the way clinical pharmacists can contribute in resource‐limited settings
S Shrestha, S Shrestha, S Khanal - Aging Medicine, 2019 - Wiley Online Library
… Sunil Shrestha conceptualized the idea of this manuscript and wrote the initial version of the
manuscript. Sudip Shrestha added the content of the manuscript and revised it substantially. …
manuscript. Sudip Shrestha added the content of the manuscript and revised it substantially. …
Reduced behavioral flexibility in autism spectrum disorders.
…, ME Ragozzino, MW Mosconi, S Shrestha… - …, 2013 - psycnet.apa.org
Objective: Restricted and repetitive behaviors, and a pronounced preference for behavioral
and environmental consistency, are distinctive characteristics of autism spectrum disorders (…
and environmental consistency, are distinctive characteristics of autism spectrum disorders (…
[HTML][HTML] Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six Southeast Asian countries
…, Y Aung, SM Borkar, MY Essar, S Shrestha… - Tropical medicine and …, 2022 - Springer
Background Vaccines are effective and reliable public health interventions against viral
outbreaks and pandemics. However, hesitancy regarding the Coronavirus disease (COVID-19) …
outbreaks and pandemics. However, hesitancy regarding the Coronavirus disease (COVID-19) …
[HTML][HTML] AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal
R Sah, S Shrestha, R Mehta, SK Sah… - Travel medicine and …, 2021 - ncbi.nlm.nih.gov
The world is in desperate need of effective vaccines against the Coronavirus Disease 2019 (COVID-19)[1].
Currently, there are 78 vaccine candidates, ongoing 201 trials, and increasing…
Currently, there are 78 vaccine candidates, ongoing 201 trials, and increasing…
[HTML][HTML] Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of …
…, KA El-Fass, S Bhattacharya, S Shrestha… - PLoS neglected …, 2022 - journals.plos.org
Background Mass vaccination campaigns have significantly reduced the COVID-19 burden.
However, vaccine hesitancy has posed significant global concerns. The purpose of this …
However, vaccine hesitancy has posed significant global concerns. The purpose of this …
Heterologous prime–boost strategies for COVID-19 vaccines
Background/Objective Heterologous prime–boost doses of COVID-19 vaccines (‘mix-and-match’
approach) are being studied to test for the effectiveness of Oxford (AZD1222), Pfizer (…
approach) are being studied to test for the effectiveness of Oxford (AZD1222), Pfizer (…
Seasonal variation of ozone and black carbon observed at Paknajol, an urban site in the Kathmandu Valley, Nepal
…, B Adhikary, R Duchi, SD Shrestha… - Atmospheric …, 2015 - acp.copernicus.org
The Kathmandu Valley in south Asia is considered as one of the global “hot spots” in terms
of urban air pollution. It is facing severe air quality problems as a result of rapid urbanization …
of urban air pollution. It is facing severe air quality problems as a result of rapid urbanization …
Evaluation of conflicts of interest among participants of the Japanese nephrology clinical practice guideline
…, T Sawano, S Shrestha, R Shrestha… - Clinical Journal of the …, 2022 - journals.lww.com
Results Among 142 authors, 125 authors (88%) received $6,742,889 in personal payments
from 56 pharmaceutical companies between 2016 and 2019. Four-year combined median …
from 56 pharmaceutical companies between 2016 and 2019. Four-year combined median …